Sezary syndrome - Unmasked by cyclosporine [2]

International Journal of Dermatology

Volumn 37, Issue 12, 1998, Pages 957-958

  Thomas, M ^a   Chandi, S M ^a   George, S ^a   Pulimood, S ^a   Sitaram, U ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETRETINATE; METHOTREXATE; STEROID;

ADULT; BLOOD SMEAR; CASE REPORT; CLINICAL EXAMINATION; DRUG EFFECT; ERYTHRODERMA; HUMAN; LETTER; MALE; SEZARY SYNDROME;

EID: 0032425251     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00560.x     Document Type: Letter

References (6)

1. 1 Grossman, RM & Chevret, S. et al. Long term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol. ; 1996, 132, 623 629.
2. 2 Tomson, Crv, Graham, S, Hutchinson, RM et al. Sezary cell lymphoma following cyclosporine immunosuppression for renal transplantation. Nephrol Dial Transplant. ; 1991, 6, 896 898.
3. 3 Bagot, M & Dubertret, L. Lymphocytic Infiltrates of the Skin in Association with Cyclosporine Therapy ( letter to the, ed..). J Am Acad Dermatol. ; 26: 283 1992.
4. 4 Caterall, MD, Addis, BJ, Smith, JL et al. Sezary syndrome: transormation to a high grade T‐cell lymphoma after treatment with Cyclosporine A. Clin Exp Dermatol. ; 1983, 8, 159 169.
5. 5 Stern, RS, Fitzgerald, E, Ellis, CN et al. The safety of etretinate as long term therapy for psoriasis: results of the etretinate follow‐up study. J Am Acad Dermatol. ; 1995, 33, 45 52.
6. 6 Buechner, SA & Winkelmann, RK. Pre‐Sezary erythroderma evolving to Sezary syndrome. Arch Dermatol. ; 1983, 119, 285 291.